Latest Commercialization News

Proteomics International has published clinical validation results for PromarkerEso, a novel blood test that detects esophageal adenocarcinoma with remarkable accuracy, promising a non-invasive alternative to costly and uncomfortable endoscopy procedures.

Sparc Technologies has successfully closed its Share Purchase Plan, raising more than double its initial target, signaling strong shareholder confidence as it advances its green hydrogen and graphene projects.

Proteomics International has completed a $12 million capital raise, including a heavily oversubscribed Share Purchase Plan, to fast-track the rollout of its innovative diagnostic tests in Australia and the USA.

PainChek has advanced its US regulatory approval process with a positive FDA meeting, setting the stage for a potential market debut of its pain assessment app in late 2025.

IperionX has secured a significant U.S. Department of Defense contract worth up to US$99 million to supply low-cost, high-performance titanium components, marking a major step in reshoring critical materials manufacturing.

Maas Group Holdings has reaffirmed its FY25 underlying EBITDA guidance between $215 million and $245 million, while expanding its Melbourne construction materials hub through key acquisitions in asphalt paving and recycling.

NH3 Clean Energy has signed a non-binding MoU with the Angel CCS Project JV to collaborate on carbon capture and sequestration for its WAH2 clean ammonia project, marking a key step toward its mid-2025 FEED entry.

Sarytogan Graphite Limited’s flagship deposit in Kazakhstan has been designated a Strategic Project under the EU’s Critical Raw Materials Act, positioning it as a key supplier for Europe’s battery and industrial sectors.

Aeris Resources has secured a $60 million Guarantee Facility with Washington H. Soul Pattinson, replacing its ANZ environmental bonding, and extended its $50 million Term Facility to August 2026 under favourable terms.

Cardiex Limited has successfully raised $2.4 million through an institutional placement to boost manufacturing and commercial activities for its CONNEQT Pulse device.

Empire Energy Group has launched a $28 million equity raise to finance critical development activities in the Beetaloo Basin, targeting first gas sales from its Carpentaria Pilot Project in 2025. The capital raise, combined with a $65 million financing package, underpins the company’s ambition to commercialize one of Australia’s largest low-CO2 shale gas resources.

OncoSil Medical has launched a Security Purchase Plan offering discounted shares and free options to eligible shareholders, aiming to accelerate commercialization of its pancreatic cancer treatment device.